Merck & Co., Inc. (MRK)
150.72
-1.83
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
151.39
+0.67
(+0.44%)
After-Hours: 20:00
Merck Profit Margin (Quarterly) : -8.06% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.06% |
| March 31, 2026 | -26.19% |
| December 31, 2025 | 18.15% |
| September 30, 2025 | 33.68% |
| June 30, 2025 | 28.03% |
| March 31, 2025 | 32.56% |
| December 31, 2024 | 24.49% |
| September 30, 2024 | 18.91% |
| June 30, 2024 | 33.80% |
| March 31, 2024 | 30.15% |
| December 31, 2023 | -8.62% |
| September 30, 2023 | 29.67% |
| June 30, 2023 | -39.64% |
| March 31, 2023 | 19.37% |
| December 31, 2022 | 24.17% |
| September 30, 2022 | 21.38% |
| June 30, 2022 | 26.68% |
| March 31, 2022 | 26.97% |
| December 31, 2021 | 27.44% |
| September 30, 2021 | 34.86% |
| June 30, 2021 | 10.70% |
| March 31, 2021 | 26.13% |
| December 31, 2020 | -23.97% |
| September 30, 2020 | 21.34% |
| June 30, 2020 | 25.17% |
| Date | Value |
|---|---|
| March 31, 2020 | 26.82% |
| December 31, 2019 | 20.02% |
| September 30, 2019 | 15.48% |
| June 30, 2019 | 22.64% |
| March 31, 2019 | 26.54% |
| December 31, 2018 | 16.19% |
| September 30, 2018 | 18.13% |
| June 30, 2018 | 16.59% |
| March 31, 2018 | 7.31% |
| December 31, 2017 | -9.93% |
| September 30, 2017 | -0.49% |
| June 30, 2017 | 19.75% |
| March 31, 2017 | 16.66% |
| December 31, 2016 | -5.84% |
| September 30, 2016 | 20.85% |
| June 30, 2016 | 12.36% |
| March 31, 2016 | 12.32% |
| December 31, 2015 | 9.79% |
| September 30, 2015 | 18.49% |
| June 30, 2015 | 7.17% |
| March 31, 2015 | 10.35% |
| December 31, 2014 | 70.49% |
| September 30, 2014 | 8.00% |
| June 30, 2014 | 18.60% |
| March 31, 2014 | 16.86% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
| Pfizer Inc. | -1.64% |
| Bristol Myers Squibb Co. | 25.54% |
| Abbott Laboratories | 7.37% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.56% |
| Return on Assets | 2.47% |
| Return on Invested Capital | 3.36% |
| Gross Profit Margin (Quarterly) | 71.51% |
| Operating Margin (Quarterly) | 4.90% |
| Return on Net Operating Assets | 3.62% |